发明名称 |
CELL LINE-BASED REDIRECTED T-CELL CYTOTOXICITY ASSAY |
摘要 |
This disclosure provides a cell-based assay for testing the potency of multispecific binding molecules which specifically bind a T-cell antigen and a target antigen for redirected T-cell-mediated cellular cytotoxicity. The assay uses the TALL-104 T-cell line as effector cells, and provides a sensitive, specific, and reproducible method for ensuring that purity, activity, and stability of multispecific binding molecule batches can be measured for development, clinical trials, and commercial marketing. |
申请公布号 |
US2017089885(A1) |
申请公布日期 |
2017.03.30 |
申请号 |
US201515126922 |
申请日期 |
2015.03.18 |
申请人 |
APTEVO RESEARCH AND DEVELOPMENT LLC |
发明人 |
Blankenship John;Sewell Elaine;Lowe Richard |
分类号 |
G01N33/50;C07K16/30;C07K16/32;C07K16/28 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of measuring the cytotoxic potential of a multispecific binding molecule comprising:
a. contacting the multispecific binding molecule with an immortalized cytotoxic T-cell (CTL) effector cell, wherein the CTL effector cell is a TALL-104 cell (ATCC CRL 11386), and wherein the multispecific binding molecule specifically binds the CTL effector cell via a T-cell (TC) antigen binding domain; b. contacting the multispecific binding molecule with a target cell, wherein the target cell expresses a target antigen, and wherein the multispecific binding molecule specifically binds to the target cell via a target antigen binding domain; and c. determining the extent of specific target cell death upon formation of an effector cell-multispecific binding molecule-target cell complex, thereby determining the cytotoxic potential of the multispecific binding molecule. |
地址 |
Seattle WA US |